These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 10442253)
1. The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease. de la Fuente-Fernández R; Núñez MA; López E Clin Neuropharmacol; 1999; 22(4):226-30. PubMed ID: 10442253 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations. Camicioli R; Rajput A; Rajput M; Reece C; Payami H; Hao C; Rajput A Mov Disord; 2005 Aug; 20(8):989-94. PubMed ID: 15852364 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease. Feldman B; Chapman J; Korczyn AD Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E gene polymorphism and the risk of cervical myelopathy in patients with chronic spinal cord compression. Setzer M; Hermann E; Seifert V; Marquardt G Spine (Phila Pa 1976); 2008 Mar; 33(5):497-502. PubMed ID: 18317192 [TBL] [Abstract][Full Text] [Related]
5. [Association between polymorphism of alpha 1-antichymotrypsin and apolipoprotein E gene and Parkinson's disease in Shanghai Hans]. Hao Y; Xie H; Xu L Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1172-5. PubMed ID: 11769703 [TBL] [Abstract][Full Text] [Related]
6. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease. Blázquez L; Otaegui D; Sáenz A; Paisán-Ruiz C; Emparanza JI; Ruiz-Martinez J; Moreno F; Martí-Massó JF; López de Munain A Neurosci Lett; 2006 Oct; 406(3):235-9. PubMed ID: 16904828 [TBL] [Abstract][Full Text] [Related]
8. Absence of the apolipoprotein E epsilon4 allele is associated with working memory impairment in Parkinson's disease. Tröster AI; Fields JA; Paolo AM; Koller WC J Neurol Sci; 2006 Oct; 248(1-2):62-7. PubMed ID: 16769085 [TBL] [Abstract][Full Text] [Related]
9. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease. Cui T; Zhou X; Jin W; Zheng F; Cao X Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232 [TBL] [Abstract][Full Text] [Related]
10. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Koller WC; Glatt SL; Hubble JP; Paolo A; Tröster AI; Handler MS; Horvat RT; Martin C; Schmidt K; Karst A Ann Neurol; 1995 Feb; 37(2):242-5. PubMed ID: 7847865 [TBL] [Abstract][Full Text] [Related]
12. [Apolipoprotein E gene polymorphisms and Alzheimer disease]. Chen D; Zhang JW; Zhang ZX; Zhao HL; Li XQ; Wu YN; Qu QM Yi Chuan Xue Bao; 2003 Dec; 30(12):1167-70. PubMed ID: 14986436 [TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset. Parsian A; Racette B; Goldsmith LJ; Perlmutter JS Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377 [TBL] [Abstract][Full Text] [Related]
14. [The absence of a relation between apolipoprotein E genotypes and the severity of multiple sclerosis in Mexican patients]. Corona T; Guerrero-Camacho JL; Alonso-Vilatela ME; Flores-Rivera Jde J Rev Neurol; 2010 Jan 1-15; 50(1):19-22. PubMed ID: 20073019 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon4 allele is associated with left ventricular systolic dysfunction. Bleumink GS; van Duijn CM; Kingma JH; Witteman JC; Hofman A; Stricker BH Am Heart J; 2004 Apr; 147(4):685-9. PubMed ID: 15077085 [TBL] [Abstract][Full Text] [Related]
16. Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy. Bosco P; Guéant-Rodríguez RM; Anello G; Spada RS; Romano A; Caraci F; Ferri R; Guéant JL Neurosci Lett; 2005 Nov; 388(3):168-72. PubMed ID: 16040191 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system. Goldman JG; Goetz CG; Berry-Kravis E; Leurgans S; Zhou L Arch Neurol; 2004 Aug; 61(8):1280-4. PubMed ID: 15313848 [TBL] [Abstract][Full Text] [Related]
18. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease. Raygani AV; Zahrai M; Soltanzadeh A; Doosti M; Javadi E; Pourmotabbed T Neurosci Lett; 2004 Nov; 371(2-3):142-6. PubMed ID: 15519745 [TBL] [Abstract][Full Text] [Related]
19. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]